Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$9,582,542
+$494,019 QoQ
Shares Held
37,731
+1.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
#1,137
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2025CallValue
$16,584
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Royal Fund Management, LLC holds $53,687,214 across 9 Drug Manufacturers - General names. JNJ ranks #2 (17.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
50,828 | $12,790,357 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
37,731 | $9,582,542 | |
| 3 | MRK |
Merck & Co., Inc.
|
71,225 | $9,152,412 | |
| 4 | AMGN |
Amgen Inc
|
22,196 | $8,037,615 | |
| 5 | LLY |
ELI LILLY & Co
|
5,141 | $6,166,270 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
67,139 | $3,868,549 | |
| 7 | GSK |
GSK plc
|
36,119 | $1,893,357 | |
| 8 | PFE |
Pfizer Inc
|
77,701 | $1,871,040 |
All Filings in JNJ
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,582,542 | 37,731 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $9,088,523 | 37,181 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $7,806,154 | 37,720 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $4,343,648 | 23,426 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $4,289,220 | 28,080 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $16,584 | 100 | Call | Sole | 2025-05-14 | |
| 2025-03-31 | $4,176,182 | 25,182 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,510,119 | 31,186 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $4,942,181 | 30,496 | Shares | Sole | 2024-10-08 | |
| 2024-09-30 | $113,442 | 700 | Call | Sole | 2024-10-08 | |
| 2024-06-30 | $4,504,943 | 30,822 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $4,975,708 | 31,454 | Shares | Sole | 2024-04-11 | |
| 2024-03-31 | $126,552 | 800 | Call | Sole | 2024-04-11 | |
| 2023-12-31 | $141,066 | 900 | Call | Sole | 2024-02-06 | |
| 2023-12-31 | $4,617,560 | 29,460 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,558,646 | 29,269 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $4,917,599 | 29,710 | Shares | Sole | 2023-07-12 | |
| 2023-06-30 | $115,864 | 700 | Call | Sole | 2023-07-12 | |
| 2023-03-31 | $4,563,045 | 29,439 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $35,330 | 200 | Call | Sole | 2023-01-20 | |
| 2022-12-31 | $4,712,845 | 26,679 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $4,129,414 | 25,278 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,427,454 | 24,942 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $4,222,681 | 23,826 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,138,525 | 24,192 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,986,143 | 24,682 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $3,981,930 | 24,171 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $3,810,619 | 23,186 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $3,560,879 | 22,626 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $3,310,942 | 22,239 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,595,607 | 18,457 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $2,355,488 | 17,963 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||